Xiaohui Wang

Xiaohui Wang has an extensive work experience in financial analysis and business roles. Most recently, they worked at SAI360 as a Sr. Financial Analyst starting in 2023. Prior to that, they held the same position at NICE CXone from 2021 to 2022. In this role, they managed revenue budgeting and forecasting, conducted revenue analysis, and led projects to improve revenue assurance.

Before their role at NICE CXone, Xiaohui Wang worked at Meds In Motion as a Senior FP&A Analyst from 2020 to 2021. Xiaohui was responsible for creating and maintaining budgets, managing monthly budgeting reviews, and building forecast processes for sales and revenue.

From 2015 to 2020, Xiaohui Wang worked at MasterControl as a Sr. FP&A Analyst. Xiaohui'sresponsibilities included managing forecast processes, maintaining capacity models, and mapping and managing new investments in budgeting.

Xiaohui also has experience as a Business Analyst at Technology Venture and Commercialization in University of Utah from 2014 to 2015, and as a Research Associate at the CARDIOLOGY DIVISION, UNIVERSITY OF UTAH from 2007 to 2013.

Xiaohui Wang began their career as a Surgery Resident at Beijing Chaoyang Hospital from 1996 to 2000.

Xiaohui Wang obtained a Bachelor's degree in Medicine from Sun Yat-sen University of Medical Sciences in 1996. From 2000 to 2006, they pursued a Doctor of Philosophy (PhD) in Experimental Pathology at the University of Utah's Department of Pathology. Following that, they enrolled in the University of Utah's David Eccles School of Business and completed a Master of Business Administration (MBA) degree in Business Administration and Management, General from 2013 to 2015.